^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
GENE:

RELA (RELA Proto-Oncogene)

i
Other names: RELA, RELA Proto-Oncogene, NF-KB Subunit 2, Nuclear Factor Of Kappa Light Polypeptide Gene Enhancer In B-Cells 3, V-Rel Avian Reticuloendotheliosis Viral Oncogene Homolog A, Nuclear Factor NF-Kappa-B P65 Subunit, Transcription Factor P65, NFKB3, P65, NF-Kappa-B Transcription Factor P65, NF-Kappa-B P65delta3, CMCU
Associations
Trials
2d
Orbital Cellular Myofibroma: A Rare Case With Detailed Vascular Characterization. (PubMed, Ophthalmic Plast Reconstr Surg)
This case highlights the diagnostic challenges associated with orbital tumors and the importance of considering myofibroma in the differential diagnosis. The report also underscores the role of multidisciplinary management in optimizing outcomes for patients with rare orbital neoplasms.
Journal
|
RELA (RELA Proto-Oncogene)
2d
Forsythoside A Alleviates Neuroinflammatory Damage via Inhibiting TLR4/NF-κB/NLRP3 Activation-Induced Astrocyte Pyroptosis in Cerebral Ischemia-Reperfusion. (PubMed, CNS Neurosci Ther)
FA alleviates neuroinflammatory damage through inhibiting the TLR4/NF-κB axis and blocking NLRP3 inflammasome-induced astrocyte pyroptosis.
Journal • IO biomarker
|
TLR4 (Toll Like Receptor 4) • NLRP3 (NLR Family Pyrin Domain Containing 3) • RELA (RELA Proto-Oncogene)
3d
Intraocular Ependymoma in a Child - Case report. (PubMed, Retin Cases Brief Rep)
Although extremely rare, intraocular ependymoma should be included as part of the differential diagnosis of retinal and ciliary body tumors in childhood.
Journal
|
L1CAM (L1 cell adhesion molecule) • GFAP (Glial Fibrillary Acidic Protein) • OLIG2 (Oligodendrocyte Transcription Factor 2) • RELA (RELA Proto-Oncogene) • ZFTA (Zinc Finger Translocation Associated)
5d
Protective Effect of Silymarin Against Paclitaxel-Induced Cardiotoxicity. (PubMed, Food Sci Nutr)
Silymarin also reduced Caspase-3 levels while increasing Bcl-2 protein expression, an antiapoptotic protein. These results suggest that silymarin has significant therapeutic potential for reducing Paclitaxel-induced cardiotoxicity via its antioxidant, anti-inflammatory, and anti-apoptotic properties.
Journal • IO biomarker
|
BCL2 (B-cell CLL/lymphoma 2) • IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • NFKB1 (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) • CASP3 (Caspase 3) • IL1B (Interleukin 1, beta) • RELA (RELA Proto-Oncogene)
|
paclitaxel
8d
Elevated TNF-α level is correlated with NF-κB/p65 activation in patients with sporadic colorectal cancer. (PubMed, Mol Clin Oncol)
The findings of the present study highlighted the TNF-α/NF-κB signaling pathway role in CRC development and may serve as a potential diagnostic and prognostic marker for the disease. Further research could provide valuable insights into the clinical implications of targeting this pathway in CRC diagnosis and treatment.
Journal
|
TNFA (Tumor Necrosis Factor-Alpha) • RELA (RELA Proto-Oncogene)
9d
Molecular Biology and Phase 1 Study of GM-CSF and Intrathecal Trastuzumab in Children with Recurrent Posterior Fossa Ependymoma. (PubMed, Neuro Oncol)
IT trastuzumab in combination with GM-CSF is safe in recurrent pediatric PF EPN. A larger phase 2 study that includes both recurrent PFA and RELA-ST EPN is needed to determine the long-term efficacy of this immunotherapy strategy.
P1 data • Journal • IO biomarker
|
HER-2 (Human epidermal growth factor receptor 2) • CSF2 (Colony stimulating factor 2) • RELA (RELA Proto-Oncogene)
|
Herceptin (trastuzumab)
13d
Design, synthesis and anti-tumor activation of β-carboline alkaloids derivatives from Picrasma quassioides. (PubMed, Fitoterapia)
Molecular docking results showed that compound 4 could form a stable binding conformation with p65, ERK 1 and ERK 2 target proteins through intermolecular forces such as van der Waals force and hydrogen bond, among which the binding affinity with ERK 1 was the strongest. This finding provides experimental basis and theoretical support for the development of targeted anticancer drugs derived from natural products.
Journal
|
RELA (RELA Proto-Oncogene)
14d
The Presence of SFRP1 Reduces the High Risk of Metastasis in RANKL-Expressing Canine Mammary Cancers. (PubMed, Animals (Basel))
Our study identified RANKL expression as a strong marker for cancer progression with a strong link to vascular-invasive cells. However, SFRP1 expression may potentially suppress the pro-metastatic nature of RANKLpos CMCs.
Journal
|
SFRP1 (Secreted frizzled related protein 1) • RELA (RELA Proto-Oncogene) • TNFSF11 (TNF Superfamily Member 11)
16d
FOS and FOSB Immunohistochemistry and Molecular Testing Reveal Novel Patterns in Proliferative Fasciitis and Myositis, FOSB Rearrangement in Proliferative Funiculitis, and FOSL1::RELA Fusion in Pediatric Proliferative Fasciitis. (PubMed, Am J Surg Pathol)
Some PFU and pediatric PFA harbored alterations in related genes FOSB and FOSL1, respectively. RNAseq and FISH might have imperfect sensitivity for FOS alterations in PFA/PM, likely due to the low relative neoplastic cell content in these tumor types.
Journal
|
FOSL1 (FOS Like 1) • RELA (RELA Proto-Oncogene)
16d
Dominant clones leverage developmental epigenomic states to drive ependymoma. (PubMed, Nature)
In vivo lineage tracing studies identified neoplastic clones that aggressively dominated tumour growth and established the entire EPN cellular hierarchy. These findings identify developmental epigenomic states that are critical for fusion-oncoprotein-driven transformation and show how these states continue to shape tumour progression.
Journal
|
RELA (RELA Proto-Oncogene) • ZFTA (Zinc Finger Translocation Associated)
16d
PEAR1/EAF1 deficiency impairs aspirin responsiveness in atherosclerotic endothelium: A novel mechanism of atypical aspirin resistance. (PubMed, Microvasc Res)
The PEAR1/EAF1 interaction ameliorates aspirin resistance in atherosclerosis. This effect is associated with suppression of the endothelial NF-κB/NLRP3 inflammatory signaling pathway and altered endothelial cell fate under inflammatory stress. Targeting the PEAR1/EAF1 interaction represents a novel potential therapeutic strategy for overcoming AR.
Journal
|
TNFA (Tumor Necrosis Factor-Alpha) • NLRP3 (NLR Family Pyrin Domain Containing 3) • RELA (RELA Proto-Oncogene)
|
aspirin
24d
Epigenetic context defines the transcriptional activity of canonical and noncanonical NF-κB signaling in pancreatic cancer. (PubMed, Cell Death Discov)
TNFα engages a broader transcriptional program via RELA, whereas TWEAK targets a more selective set of genes marked by chromatin accessibility and AP1 co-binding through RELB. This study provides critical insight into the regulatory dynamics of NF-κB signaling in pancreatic cancer and highlights the specialized functions of RELA and RELB in modulating gene expression and tumor-microenvironment interactions.
Journal
|
TNFA (Tumor Necrosis Factor-Alpha) • RELA (RELA Proto-Oncogene)